Skip to content
  • Live News
  • Topics
  • Headlines
MarketNewsData
Essential Market News. Zero Noise.
  • Live News
  • Topics
  • Headlines

Category: Earnings

Adial Pharmaceuticals achieves key milestones for drug AD04, secures FDA approval and new patents.

From GlobeNewswire: 2025-03-04 08:30:00 Adial Pharmaceuticals, Inc. reported successful completion of a key pharmacokinetics study for AD04, confirming bioavailability and

March 4, 2025

Best Buy exceeds earnings expectations in Q4 2025 but projects price increases due to tariffs.

From CNBC: 2025-03-04 08:23:00 Best Buy exceeded expectations in fourth-quarter earnings and revenue but projects price increases for U.S. consumers

March 4, 2025

L.B. Foster Company reports profitability in 2024, authorizes new stock repurchase program

From GlobeNewswire: 2025-03-04 08:00:00 L.B. Foster Company reported improved gross margins in the fourth quarter and full year of 2024,

March 4, 2025

AutoZone's second-quarter sales increased by 2.4%, with strategy to expand into international markets

From GlobeNewswire: 2025-03-04 06:55:00 AutoZone reported net sales of $4.0 billion for the second quarter ended February 15, 2025, up

March 4, 2025

Olaplex reports decrease in net sales and income, plans investments for fiscal year 2025

From GlobeNewswire: 2025-03-04 06:45:00 Olaplex Holdings, Inc. (NASDAQ: OLPX) reported financial results for Q4 and fiscal year 2024. Net sales

March 4, 2025

Y-mAbs reported increased revenues for Q4 2024 and full year, with upcoming conference call.

From GlobeNewswire: 2025-03-04 06:35:00 Y-mAbs Therapeutics, Inc. reported revenues of $26.5 million for Q4 2024 and $87.7 million for the

March 4, 2025

Target reports Q4 earnings with raised sales guidance but struggles with discretionary merchandise

From CNBC: 2025-03-04 00:01:02 Target will report fiscal fourth-quarter earnings, with analysts expecting earnings per share of $2.26 and revenue

March 4, 2025

Dave Inc. saw strong revenue and net income growth in Q4 and full year 2024.

From GlobeNewswire: 2025-03-03 16:05:00 Dave Inc. reported a 38% increase in Q4 revenue to $100.9 million and a 34% increase

March 3, 2025

Mixed earnings reports expected for various companies on March 4, 2025.

From Nasdaq: 2025-03-03 16:00:01 Multiple companies are set to report earnings on 03/04/2025. Plug Power, Inc. (PLUG) expects a $-0.23

March 3, 2025

Major U.S. equity indices closed lower in February due to growth/stagflation concerns

From Nasdaq: 2025-03-03 16:00:00 In February, all major U.S. equity indices closed lower due to growth/stagflation concerns. 10 of 11

March 3, 2025

Mixed earnings with some companies showing decreases and some showing increases

From Nasdaq: 2025-03-03 14:00:00 Okta, Inc. (OKTA) is expected to report earnings with a forecast of $0.16 per share, a

March 3, 2025

Market downturn affecting Bitcoin and Coinbase, but MARA, CORZ, CIFR, and BTDR show potential growth

From Nasdaq: 2025-03-03 08:33:00 The cryptocurrency market, including Bitcoin and Coinbase Global (NASDAQ: COIN), is experiencing a sell-off with Bitcoin

March 3, 2025

California Resources Corporation reported strong financial results for Q4 2024 and FY 2024 with positive outlook for 2025.

From GlobeNewswire: 2025-03-03 08:32:00 California Resources Corporation (CRC) reported financial and operating results for Q4 2024 and FY 2024, with

March 3, 2025

Annexon reports strong financial performance in Q4 2024, advancing promising therapies in pipeline.

From GlobeNewswire: 2025-03-03 08:00:00 Annexon, Inc. reports robust Phase 3 data and real-world evidence supporting ANX005 as a potential first

March 3, 2025

Monroe Capital Corporation reported solid financial results for Q4 2024 and full year 2024.

From GlobeNewswire: 2025-03-03 07:35:00 Monroe Capital Corporation (NASDAQ: MRCC) announced its financial results for Q4 2024, with net investment income

March 3, 2025

TG Therapeutics reports strong BRIUMVI revenue and pipeline developments, aiming for $540 million total revenue in 2025.

From GlobeNewswire: 2025-03-03 07:00:00 TG Therapeutics, Inc. reported 2024 BRIUMVI U.S. net revenue of $103.6 million for the fourth quarter

March 3, 2025

ArriVent BioPharma shows strong clinical data for firmonertinib, expands ADC portfolio, reports financial loss.

From GlobeNewswire: 2025-03-03 07:00:00 ArriVent BioPharma reported strong clinical data for firmonertinib in first-line NSCLC EGFR PACC mutations. Achieved target

March 3, 2025

Hut 8 reports strong financial results for Q4 and full year 2024

From GlobeNewswire: 2025-03-03 06:30:00 Hut 8 Corp. announced fourth quarter and full-year 2024 financial results, highlighting revenue of $162.4 million,

March 3, 2025

Exosens exceeds revenue and profit expectations in 2024, plans for further expansion.

From GlobeNewswire: 2025-03-03 01:30:00 Exosens exceeded IPO guidance with a +35.0% revenue growth to €394.1m in 2024, boasting an adjusted

March 3, 2025

Stock market closed with gains of over 1.3% on Friday, but S&P 500 and Nasdaq dropped during the week.

From CNBC: 2025-03-02 10:37:17 Investors on Wall Street shook off concerns over geopolitical tensions sparked by Trump’s Oval Office spat

March 2, 2025

Opportunities for profit in volatile market with high volatility stocks Reed's Inc. and Oil States International

From Nasdaq: 2025-03-02 09:12:00 Volatility in the stock market can provide opportunities for profit. Reed’s Inc. (OTCMKTS: REED) and Oil

March 2, 2025

MarketWise reports strong Q4 results with $93.1M net income and positive outlook for Q1 2025

From GlobeNewswire: 2025-02-28 22:51:00 MarketWise, Inc. reported Q4 2024 financial results with 506k paid subscribers, $97.5M in total net revenue,

February 28, 2025

Retail sector earnings are strong with stable consumer spending, but Target faces lower earnings expectations.

From Nasdaq: 2025-02-28 19:23:00 This week, retail giants like Target, Best Buy, Costco, and Macy’s are set to report earnings.

February 28, 2025

Premier Health reports decreased revenues and net loss in Q1 2025, with cost reduction efforts

From GlobeNewswire: 2025-02-28 17:01:00 Premier Health of America Inc. (TSXV: PHA) filed its unaudited Quarterly Consolidated Financial Statements for Q1

February 28, 2025

4D Molecular Therapeutics reports positive data for 4D-150 in wet AMD, DME, and strong financials.

From GlobeNewswire: 2025-02-28 16:05:00 4D Molecular Therapeutics reported positive interim data for 4D-150 in wet AMD and DME, with ongoing

February 28, 2025

Posts pagination

Previous 1 … 45 46 47 … 208 Next
All Right Reserved © MarketNewsData.com.
  • Live News
  • Topics
  • Headlines
  • Contact Us
  • About Us
  • CCPA
  • Terms of Use
  • Privacy Policy
  • DMCA